Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers

(1) Background: Bladder cancer is a malignant tumor mainly caused by exposure to environmental chemicals, with a high recurrence rate. NR1H4, also known as Farnesoid X Receptor (FXR), acts as a nuclear receptor that can be activated by binding with bile acids, and FXR is highly correlated with the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chien-Rui, Wang, Hisao-Hsien, Chang, Hsin-Han, Tsai, Yu-Ling, Tsai, Wen-Chiuan, Lee, Chen-Ray, Changchien, Chih-Ying, Cheng, Yu-Chen, Wu, Sheng-Tang, Chen, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103877/
https://www.ncbi.nlm.nih.gov/pubmed/35563650
http://dx.doi.org/10.3390/ijms23095259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103877/
https://www.ncbi.nlm.nih.gov/pubmed/35563650
http://dx.doi.org/10.3390/ijms23095259

Ejemplares similares